F10 and myocardial infarction: The summary of the following meta-analyses, RE-LY, ROCKET AF, ARISTOTLE, Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction Study 48 (ENGAGE AF-TIMI), and EXPLORE Xa, was compared with dose-adjusted warfarin (INR 2-3) in Table 2 and Table 3.